PO-1227: A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma.

Authors :: Boutros, C.
Chaput, N.
Lanoy, E.
Larive, A.
Mateus, C.
Routier, E.
Roy, S.
Sun, R.
Lancia, A.
Tao, Y.G.
Ibrahim, N.
Khoury-Abboud, R.
Massard, C.
Bahleda, R.
Schwob, D.
Caramella, C.
Cassard, L.
Soria, J.
Robert, C.
Deutsch, E.
Source :: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS646-S647. 2p.
Publication Year :: 2020
Abstract: Poster: Clinical track: Skin cancer / malignant melanoma PO-1227: A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma. [Extracted from the article]

Full Text Access

Tools